Moderna Needs a Post-Covid Hit. Its Cancer-Drug Spending Plan Ups the Stakes.

Moderna Needs a Post-Covid Hit. Its Cancer-Drug Spending Plan Ups the Stakes.

来源:Barrons发布于 2026-11-12

The biotech plans to reinvest in its pipeline, particularly oncology treatments like its personalized cancer vaccine.

相关标的:MRNA

本文内容来自外部来源,点击「继续访问」将跳转到原始发布站点。